분류 전체보기 썸네일형 리스트형 My Position on Diet, Natural Healing, and Treatment I am a Stage 4 Follicular Lymphoma patient, currently on my second relapse. The next treatment option is not covered by Korean national health insurance. The cost is significant. The complete response rate is not high. And for now, I have no symptoms that require immediate intervention — so I am under active surveillance, watching and waiting. In the meantime, I started a low-carb, high-fat diet.. 더보기 1 Month on LCHF — What Actually Changed One month in. Here's what I noticed. WeightI lost 4kg in the first month. I wasn't trying to lose weight — that wasn't the point of this. But it happened. 4kg might sound modest depending on the person — but where it came from made the difference. The excess fat around my belly and thighs reduced noticeably, and it feels like I've dropped about two clothing sizes. Clothes that used to be too tig.. 더보기 The Warburg Effect — Why Cancer Loves Sugar (And What That Has to Do With My Diet) If you've spent any time researching cancer, you've probably come across some version of this idea: cancer loves sugar. It gets repeated a lot. But most of the time, nobody explains why — or what it actually means for the way you eat. I came across this concept early on after my diagnosis, and at first I just accepted it and moved on. But the more I dug into it, the more interesting it got. So t.. 더보기 Why I Switched to LCHF — And Why I Switched Back I was already eating low-carb, high-fat before my diagnosis. Not because of cancer. Not because of any protocol or research. Just because it felt right. My energy was stable, my body felt good, and the way I ate didn't feel like a diet — it felt like my normal. Then I was diagnosed with follicular lymphoma. During treatment, I kept eating loosely LCHF — not strictly, but I never fully let it go... 더보기 What Is a Bispecific Antibody? — A Simple Guide for Lymphoma Patients What Is a Bispecific Antibody?If you have been reading about newer lymphoma treatments recently, you have probably come across this term. Bispecific antibody. It shows up in articles about Lunsumio. It shows up in articles about Epcoritamab. It is becoming one of the most important concepts in lymphoma treatment right now — and once you understand how it works, a lot of things start to make sens.. 더보기 Epcoritamab (Epkinly) — A New Treatment Option for Relapsed Follicular Lymphoma Epcoritamab (Epkinly): Another Option on the HorizonFollicular Lymphoma is a rare disease. New treatment approvals don't come often — which is why I pay attention when they do. I am a Stage 4 Follicular Lymphoma patient on my second relapse. Epcoritamab is not my next treatment. But I track every new option that appears, because options are what matter when you are running out of them. What Is E.. 더보기 Lunsumio (Mosunetuzumab): What I Learned Researching My Own Next Treatment When I searched for information about Lunsumio as a relapsed Follicular Lymphoma patient, I found press releases from pharmaceutical companies. Clinical trial summaries written for oncologists. Almost nothing written by or for patients. So I researched it myself. This is what I found. Who I Am and Why I Wrote ThisI have Stage 4 Follicular Lymphoma, Grade 3A. Diagnosed February 2021. R-CHOP for f.. 더보기 My Treatment Timeline: Stage 4 Follicular Lymphoma Grade 3A This is a living document. I will update it as my treatment continues. If you have just been diagnosed with Follicular Lymphoma — or if you are somewhere in the middle of this, like me — I hope this gives you a clearer picture of what one patient's journey can look like. The DiagnosisFebruary 2021.Stage 4 Follicular Lymphoma, Grade 3A, with bone marrow involvement. A few things worth explaining .. 더보기 이전 1 2 다음
